
zzso is an emerging risk factor for chronic kidney disease zzso in the developed zzso zzso an zzso zzso zzso used in the treatment of obesity is available as an over-the-counter medication across the European union and in many countries zzso It is associated with acute kidney injury zzso We present three adults, followed up from 1 to 6 years, who developed de zzso or worsening zzso impairment while on zzso Stopping the drug halted zzso but did not reverse the degree of zzso impairment at zzso 

